CADILAHC.NS Forward P/E

The Forward P/E of Zydus Lifesciences Ltd (CADILAHC.NS) is 0.02.

Forward P/E estimates how much investors are willing to pay today for each dollar of a company's expected future earnings. It serves as a valuation tool based on projected profitability rather than past performance.

CADILAHC.NS Forward P/E - Peers Comparison

Ticker	Name	Value
GLENMARK.NS	Glenmark Pharmaceuticals Ltd	28.39
TORNTPHARM.NS	Torrent Pharmaceuticals Ltd	56.69
ALKEM.NS	Alkem Laboratories Ltd	28.36
DRREDDY.NS	Dr Reddy's Laboratories Ltd	16.58
PGHL.NS	Procter & Gamble Health Ltd	36.06
AARTIDRUGS.NS	Aarti Drugs Ltd	12.15
APLLTD.NS	Alembic Pharmaceuticals Ltd	26.77
GRANULES.NS	Granules India Ltd	25.15
JBCHEPHARM.NS	J B Chemicals and Pharmaceuticals Ltd	38.41
LUPIN.NS	Lupin Ltd	27.97
SANOFI.NS	Sanofi India Ltd	35.11
ABBOTINDIA.NS	Abbott India Ltd	45.38
AJANTPHARM.NS	Ajanta Pharma Ltd	35.27
AUROPHARMA.NS	Aurobindo Pharma Ltd	18.77
ERIS.NS	Eris Lifesciences Ltd	52.86
IPCALAB.NS	IPCA Laboratories Ltd	39.31
STAR.NS	Strides Pharma Science Ltd	16.46
SUVENPHAR.NS	Suven Pharmaceuticals Ltd	73.37
CIPLA.NS	Cipla Ltd	23.96
GLAND.NS	Gland Pharma Ltd	31.91
ORCHPHARMA.NS	Orchid Pharma Ltd	38.85
PFIZER.NS	Pfizer Ltd	33.54
NATCOPHARM.NS	Natco Pharma Ltd	7.75
GLAXO.NS	GlaxoSmithKline Pharmaceuticals Ltd	52.65
LAURUSLABS.NS	Laurus Labs Ltd	57.34